|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
da Silva HB, Amaral EP, Nolasco EL, et al:
Dissecting major signaling pathways throughout the development of
prostate cancer. Prostate cancer. 2013:9206122013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weissleder R and Pittet MJ: Imaging in the
era of molecular oncology. Nature. 452:580–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Macis G, Di Giovanni S, Di Franco D and
Bonomo L: Future perspectives for diagnostic imaging in urology:
from anatomic and functional to molecular imaging. Urologia.
80:29–41. 2013.In Italian. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wagner HN Jr: Advancing a molecular theory
of disease. J Nucl Med. 49:15N–34N. 2008.PubMed/NCBI
|
|
6
|
Engle JW, Hong H, Zhang Y, Valdovinos HF,
Myklejord DV, et al: Positron emission tomography imaging of tumor
angiogenesis with a 66Ga-labeled monoclonal antibody. Mol Pharm.
9:1441–1448. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haubner R and Decristoforo C:
Radiolabelled RGD peptides and peptidomimetics for tumour
targeting. Front Biosci (Landark Ed). 14:872–886. 2009. View Article : Google Scholar
|
|
8
|
Liu S, Liu H, Jiang H, Xu Y, Zhang H and
Cheng Z: One-step radiosynthesis of
18F-AlF-NOTA-RGD2 for tumor angiogenesis PET
imaging. Eur J Nucl Med Mol Imaging. 38:1732–1741. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Perugini M, Varelias A, Sadlon T and
D’Andrea RJ: Hematopoietic growth factor mimetics: from concept to
clinic. Cytokine Growth Factor Rev. 20:87–94. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hetian L, Ping A, Shumei S, et al: A novel
peptide isolated from a phage display library inhibits tumor growth
and metastasis by blocking the binding of vascular endothelial
growth factor to its kinase domain receptor. J Biol Chem.
227:43137–43142. 2002. View Article : Google Scholar
|
|
11
|
Shelton PT and Jensen KJ: Linker, resins,
and general procedures for solid-phase procedures for solid-phase
peptide synthesis. Methods Mol Biol. 1047:23–41. 2013.
|
|
12
|
Salacinski RP, McLean C, Sykes JE, et al:
Iodination of proteins, glycoproteins, and peptides using a
solid-phase oxidizing agent 1,3,4,6-tetrachloro-3α-6α-diphenyl
glycouril (Iodogen). Anal Biochem. 117:136–146. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Auprich M, Bjartell A, Chun FK, et al:
Contemporary role of prostate cancer antigen 3 in the management of
prostate cancer. Eur Urol. 60:1045–1054. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ren J, Wang F, Wei G, et al: MRI of
prostate cancer antigen expression for diagnosis and immunotherapy.
PLoS One. 7:e383502012. View Article : Google Scholar
|
|
15
|
Mease RC, Foss CA and Pomper MG: PET
imaging in prostate cancer: focus on prostate-specific membrane
antigen. Curr Top Med Chem. 13:951–962. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Folkman J: Role of angiogenesis in tumor
growth and metastasis. Seminars in oncology. WB Saunders. 29(6
Suppl 16): 15–18. 2002.
|
|
17
|
Prud’homme GJ and Glinka Y: Neuropilins
are multifunctional coreceptors involved in tumor initiation,
growth, metastasis and immunity. Oncotarget. 3:921–939. 2012.
|
|
18
|
Cai Y, Balli D, Ustiyan V, et al: Foxm1
expression in prostate epithelial cells is essential for prostate
carcinogenesis. J Biol Chem. 288:22527–22541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li R, Ren M, Chen N, et al: Presence of
intratumoral platelets is associated with tumor vessel structure
and metastasis. BMC Cancer. 14:1672014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roskoski R Jr: Vascular endothelial growth
factor (VEGF) signaling in tumor progression. Crit Rev Oncol
Hematol. 63:179–213. 2007. View Article : Google Scholar
|
|
21
|
Dai J and Rabie AB: VEGF: an essential
mediator of both angiogenesis and endochondral ossification. J Dent
Res. 86:937–950. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng Q, Du J, Zhang Z, et al: Association
study between of Tie2/angiopoietin-2 and VEGF/KDR pathway gene
polymorphisms and vascular malformations. Gene. 523:195–198. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang YL, Wang P, Lu YY, et al: Effects of
K237 on the proliferation of PC-3M cells and mRNA expressions of
bax and bcl-2. Zhonghua Nan Ke Xue. 15:1098–1101. 2009.In
Chinese.
|
|
24
|
Al-Saeedi FJ, Bitar M and Pariyani S:
Effect of asiaticoside on 99mTc-tetrofosmin and 99mTc-sestamibi
uptake in MCF-7 cells. J Nucl Med Technol. 39:279–283. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang H, Xia JW, Zhang ZY, et al:
Preparation of 131I-K237 and the experimental study on
targeting therapy in nude mice bearing human lung cancer. Chinese J
Nucl Med. 30:390–394. 2010.In Chinese.
|
|
26
|
Wei H, Hao X and Su M: Study on the
affinity of peptides K237 with human prostate cancer cell line
LNcap. Mod Oncol. 15:10–12. 2007.In Chinese.
|
|
27
|
Zhao Q, Yan P, Yin L, et al: Validation
study of 131I-RRL: Assessment of biodistribution, SPECT imaging and
radiation dosimetry in mice. Mol Med Rep. 7:1355–1360.
2013.PubMed/NCBI
|
|
28
|
Burnett JL and Davies AV: Investigating
the time resolution of a compact multidimensional
gamma-spectrometer. J Radioanal Nucl Chem. 288:699–703. 2011.
View Article : Google Scholar
|
